针对HER2阳性乳腺癌的向治疗中的挑战和前景
Xiyin Li1, Xueying Zhang1, Saige Yin2
1Department of Breast Cancer, Peking University Cancer Hospital Yunnan, Yunnan Cancer Hospital, the Third Affiliated Hospital, Kunming Medical University, 519 Kunzhou Road, Kunming, Yunnan 650118, China.
Critical reviews in oncology/hematology
|January 18, 2025
概括
在HER2阳性乳腺癌中,耐药性阻碍了治疗. 本综述探讨了瘤异质性和微环境变化等耐药性机制,提供了提高HER2向治疗有效性的策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 乳腺癌是全世界妇女死亡的主要原因.
- 在13-15%的病例中,HER2阳性乳腺癌的预后不佳.
- 许多患有HER2阳性乳腺癌的患者尽管接受标准治疗,但进展.
研究的目的:
- 探索 HER2 向治疗中耐药性的机制.
- 确定导致HER2阳性乳腺癌治疗失败的因素.
- 讨论克服药物耐药性的战略.
主要方法:
- 关于HER2向治疗耐药性的当前文献的综述.
- 分析包括瘤异质性,抗体有效性,瘤微环境和信号通路在内的因素.
- 识别潜在的治疗策略.
主要成果:
- 耐药性是多因素的,涉及瘤特征和瘤微环境.
- 具体的机制包括瘤异质性,抗体结合的改变,微环境变异和异常信号传递.
- 有几种策略可以潜在地抵消这些抵抗机制.
结论:
- 了解耐药性对于改善HER2向治疗结果至关重要.
- 解决已识别的耐药性因素可以提高治疗疗效.
- 为了获得更好的临床益处,需要对抗药机制和新策略进行进一步的研究.
更多相关视频
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.2K
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
2.5K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
